PT820284E - Derivados de ureido biologicamente activos uteis no tratamento de esclerose multipla - Google Patents
Derivados de ureido biologicamente activos uteis no tratamento de esclerose multipla Download PDFInfo
- Publication number
- PT820284E PT820284E PT97904356T PT97904356T PT820284E PT 820284 E PT820284 E PT 820284E PT 97904356 T PT97904356 T PT 97904356T PT 97904356 T PT97904356 T PT 97904356T PT 820284 E PT820284 E PT 820284E
- Authority
- PT
- Portugal
- Prior art keywords
- methyl
- bis
- carbonyl
- sulfonic acid
- imino
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/4025—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Immunology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyrrole Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9602721.4A GB9602721D0 (en) | 1996-02-09 | 1996-02-09 | Biologically active ureido derivatives useful in the treatment of multiple sclerosis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT820284E true PT820284E (pt) | 2000-07-31 |
Family
ID=10788461
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT97904356T PT820284E (pt) | 1996-02-09 | 1997-01-24 | Derivados de ureido biologicamente activos uteis no tratamento de esclerose multipla |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US5859046A (ko) |
| EP (1) | EP0820284B1 (ko) |
| JP (1) | JPH11504041A (ko) |
| KR (1) | KR19980703718A (ko) |
| AR (1) | AR005724A1 (ko) |
| AT (1) | ATE189388T1 (ko) |
| AU (1) | AU1720097A (ko) |
| BR (1) | BR9702075A (ko) |
| CA (1) | CA2217008A1 (ko) |
| DE (1) | DE69701243T2 (ko) |
| DK (1) | DK0820284T3 (ko) |
| EA (1) | EA000166B1 (ko) |
| ES (1) | ES2144844T3 (ko) |
| GB (1) | GB9602721D0 (ko) |
| GR (1) | GR3033332T3 (ko) |
| HU (1) | HUP9900796A2 (ko) |
| IL (1) | IL121808A0 (ko) |
| NO (1) | NO974651L (ko) |
| PL (1) | PL322717A1 (ko) |
| PT (1) | PT820284E (ko) |
| WO (1) | WO1997028796A1 (ko) |
| ZA (1) | ZA97902B (ko) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1999027939A1 (en) * | 1997-12-04 | 1999-06-10 | The Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services | Ureido derivatives of poly-4-amino-2-carboxy-1-methyl pyrrole compounds for inhibition of inflammation |
| GB9727524D0 (en) | 1997-12-31 | 1998-02-25 | Pharmacia & Upjohn Spa | Synergistic antitumor composition containing a biologically active ureido compound |
| US6348464B1 (en) | 1999-11-12 | 2002-02-19 | Guilford Pharmaceuticals, Inc. | Pyrrolecarbonylimino derivatives as naaladase inhibitors |
| DK1599461T3 (da) | 2003-03-03 | 2009-08-17 | Eisai Corp North America | Thiolactoner som NAALADase-inhibitorer |
| EP3381897A1 (en) | 2017-03-27 | 2018-10-03 | Leadiant Biosciences SA | Derivatives of the disodium 2,2'-{carbonylbis[imino-3,1-phenylenecarbonylimino(1-methyl-1h-pyrrole-4,2-diyl)carbonylimino]}dinaphthalene-1,5-disulfonate salt and related compounds as heparanase inhibitors for the treatment of cancer |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9304589D0 (en) * | 1993-03-05 | 1993-04-21 | Erba Carlo Spa | Biologically active ureido derivatives useful as antimetastic agents |
| GB9307948D0 (en) * | 1993-04-16 | 1993-06-02 | Erba Carlo Spa | Biologically active ureido derivatives useful in the treatment of lentivirus-induced disease |
-
1996
- 1996-02-09 GB GBGB9602721.4A patent/GB9602721D0/en active Pending
-
1997
- 1997-01-24 PT PT97904356T patent/PT820284E/pt unknown
- 1997-01-24 HU HU9900796A patent/HUP9900796A2/hu unknown
- 1997-01-24 PL PL97322717A patent/PL322717A1/xx unknown
- 1997-01-24 EA EA199700302A patent/EA000166B1/ru not_active IP Right Cessation
- 1997-01-24 DK DK97904356T patent/DK0820284T3/da active
- 1997-01-24 AU AU17200/97A patent/AU1720097A/en not_active Abandoned
- 1997-01-24 US US08/930,598 patent/US5859046A/en not_active Expired - Fee Related
- 1997-01-24 CA CA002217008A patent/CA2217008A1/en not_active Abandoned
- 1997-01-24 WO PCT/EP1997/000412 patent/WO1997028796A1/en not_active Application Discontinuation
- 1997-01-24 ES ES97904356T patent/ES2144844T3/es not_active Expired - Lifetime
- 1997-01-24 BR BR9702075A patent/BR9702075A/pt not_active Application Discontinuation
- 1997-01-24 IL IL12180897A patent/IL121808A0/xx unknown
- 1997-01-24 EP EP97904356A patent/EP0820284B1/en not_active Expired - Lifetime
- 1997-01-24 JP JP9528110A patent/JPH11504041A/ja active Pending
- 1997-01-24 DE DE69701243T patent/DE69701243T2/de not_active Expired - Fee Related
- 1997-01-24 AT AT97904356T patent/ATE189388T1/de not_active IP Right Cessation
- 1997-01-24 KR KR1019970707118A patent/KR19980703718A/ko not_active Application Discontinuation
- 1997-02-04 ZA ZA9700902A patent/ZA97902B/xx unknown
- 1997-02-06 AR ARP970100464A patent/AR005724A1/es unknown
- 1997-10-08 NO NO974651A patent/NO974651L/no unknown
-
2000
- 2000-04-26 GR GR20000401016T patent/GR3033332T3/el not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| EA000166B1 (ru) | 1998-10-29 |
| ZA97902B (en) | 1997-08-01 |
| EP0820284A1 (en) | 1998-01-28 |
| WO1997028796A1 (en) | 1997-08-14 |
| IL121808A0 (en) | 1998-02-22 |
| MX9707673A (es) | 1997-11-29 |
| DK0820284T3 (da) | 2000-07-24 |
| GR3033332T3 (en) | 2000-09-29 |
| ATE189388T1 (de) | 2000-02-15 |
| JPH11504041A (ja) | 1999-04-06 |
| PL322717A1 (en) | 1998-02-16 |
| AU1720097A (en) | 1997-08-28 |
| KR19980703718A (ko) | 1998-12-05 |
| DE69701243D1 (de) | 2000-03-09 |
| EP0820284B1 (en) | 2000-02-02 |
| DE69701243T2 (de) | 2000-09-07 |
| US5859046A (en) | 1999-01-12 |
| BR9702075A (pt) | 1998-06-09 |
| AR005724A1 (es) | 1999-07-14 |
| CA2217008A1 (en) | 1997-08-14 |
| ES2144844T3 (es) | 2000-06-16 |
| NO974651D0 (no) | 1997-10-08 |
| EA199700302A1 (ru) | 1998-04-30 |
| NO974651L (no) | 1997-12-02 |
| GB9602721D0 (en) | 1996-04-10 |
| HUP9900796A2 (hu) | 1999-07-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20060189682A1 (en) | Water soluble prodrugs of COX-2 inhibitors | |
| ES2751652T3 (es) | Tratamiento con inhibidor de caspasa emricasan de las complicaciones por las enfermedades hepáticas crónicas | |
| PT736004E (pt) | (2,4-dissulfofenil)-n-terc-butil-nitrona seus sais e sua utilizacao como agentes farmaceuticos capturadores de radicais livres | |
| JP2016522831A (ja) | 炎症を予防および治療するためのクリオピリン阻害剤 | |
| OA11924A (en) | Methods for treatment of sickle cell anemia. | |
| PT96455B (pt) | Processo para a preparacao de novos derivados ureidicos de compostos poli-4-amino-2-carboxi-1-metilicos e de composicoes farmaceuticas que os contem | |
| ES2802977T3 (es) | Compuesto para la modulación inmunológica, uso del mismo y composición farmacéutica que lo comprende | |
| US20030022923A1 (en) | Methods for treatment of sickle cell anemia | |
| ES2287495T3 (es) | Forma polimorfa cristalina de clorhidrato de irinotecan. | |
| AU2006329879A1 (en) | Compounds and methods for inhibiting the interaction of Bcl proteins with binding partners | |
| ES2354317T3 (es) | Derivados de mononitrato de isosorbida para el tratamiento de trastornos intestinales. | |
| JP7309607B2 (ja) | テビペネムピボキシル臭化水素酸塩の結晶形、および医薬組成物 | |
| ES2615731T3 (es) | Agonista del receptor de ghrelina para el tratamiento de caquexia | |
| JP2002538177A (ja) | 新形成治療におけるインテグリンアンタゴニストおよび化学療法剤の使用 | |
| PT820284E (pt) | Derivados de ureido biologicamente activos uteis no tratamento de esclerose multipla | |
| BRPI0707089A2 (pt) | derivados de camptotecina e seus usos | |
| EP3431478B1 (en) | Micromolecular lung-targeting drug | |
| PT1457492E (pt) | Cristais de um derivado de taxano e processo para a sua produção | |
| BR112019013493A2 (pt) | Compostos heterocíclicos e seus usos | |
| US20040138233A1 (en) | Novel urokinase inhibitors | |
| US20180022734A1 (en) | Sunitinib prodrug and pharmaceutical composition | |
| CN113413378A (zh) | 一种包含绿原酸的药物组合物在制备治疗早期阿尔茨海默病的药物中的用途 | |
| CN107619428B (zh) | 鸟氨酸与门冬氨酸二肽化合物的酰化衍生物及其应用 | |
| JPH0840893A (ja) | インターロイキン−１産生抑制剤 | |
| BRPI0611096A2 (pt) | (5z)-5-(6-quinoxalinilmetilideno)-2-[(2,6-diclorofenil)a mino]-1,3-tiazol-4(5h)-ona |